Literature DB >> 7926882

Contrast sensitivity after resolution of central serous retinopathy.

P Koskela1, L Laatikainen, K von Dickhoff.   

Abstract

The contrast sensitivity of 21 patients was measured using TV equipment (Wavetek 143 function generator and Sony PVM-90CE video monitor) and the Vistech test 6-15 years after the acute stage of central serous retinopathy. In the majority of cases contrast sensitivity was lower in the affected eye. The difference between the affected and the fellow eye was statistically significant at 1 and 6 cycles/degree (c/d) but not at 19 c/d. In 13/21 cases (62%) the results of the Vistech test were consistent with those of the TV test. Contrast sensitivity did not correlate with the duration of the disease or with the ultimate clinical picture of the macula. At 6 c/d there was a statistically significant correlation between visual acuity and contrast sensitivity. If the visual acuity was less than 1.0, contrast sensitivity was decreased, but decreased contrast sensitivity was also observed in four eyes with normal visual acuity, indicating that the level of visual deficit may not be established by measurement of visual acuity alone.

Entities:  

Mesh:

Year:  1994        PMID: 7926882     DOI: 10.1007/bf00195356

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  9 in total

1.  [Retinal pigment epithelial changes related to central serous retinopathy].

Authors:  K V Dickhoff; M Hoffren; L Laatikainen
Journal:  J Fr Ophtalmol       Date:  1989       Impact factor: 0.818

2.  Vistech VCTS 6500 charts--within- and between-session reliability.

Authors:  B C Reeves; J M Wood; A R Hill
Journal:  Optom Vis Sci       Date:  1991-09       Impact factor: 1.973

3.  Central visual function in patients with resolved central serous retinopathy. A long term follow-up study.

Authors:  J A Mutlak; G N Dutton; M Zeini; D Allan; A Wail
Journal:  Acta Ophthalmol (Copenh)       Date:  1989-10

4.  Contrast sensitivity in amblyopia. I. Changes during CAM treatment.

Authors:  P U Koskela
Journal:  Acta Ophthalmol (Copenh)       Date:  1986-06

5.  Ruby laser photocoagulation therapy of central serous retinopathy. I. A controlled clinical study. II. Factors affecting prognosis.

Authors:  R C Watzke; T C Burton; P E Leaverton
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1974 Mar-Apr

6.  Comparison of three methods for rapid determination of threshold contrast sensitivity.

Authors:  A P Ginsburg; M W Cannon
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-06       Impact factor: 4.799

7.  Temporal contrast sensitivity in central serous choroidopathy.

Authors:  F Kayazawa; T Yamamoto; M Itoi
Journal:  Ann Ophthalmol       Date:  1982-03

8.  Pathogenesis of disciform detachment of the neuroepithelium.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

9.  Contrast sensitivity in macular disease. A preliminary report.

Authors:  J Sjöstrand; L Frisén
Journal:  Acta Ophthalmol (Copenh)       Date:  1977-06
  9 in total
  10 in total

1.  Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up.

Authors:  A Arsan; H S Kanar; A Sonmez
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

2.  Pattern ERG in central serous retinopathy.

Authors:  Jawahar Lal Goyal; Basudeb Ghosh; Vishram Sangit; Sushil Kumar; Parul Jain; Vikas Veerwal; Ritu Arora
Journal:  Doc Ophthalmol       Date:  2014-12-27       Impact factor: 2.379

3.  Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.

Authors:  Young Gun Park; Seungbum Kang; Minhee Kim; Nari Yoo; Young Jung Roh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-18       Impact factor: 3.117

Review 4.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

5.  Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy.

Authors:  Mehmed Uğur Işık; Mehmet Fatih Kağan Değirmenci; Ayhan Sağlık
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

6.  Contrast sensitivity in patients recovered from central serous chorioretinopathy.

Authors:  T Maaranen; M Mäntyjärvi
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

7.  Pattern of Contrast Sensitivity Changes in Acute Central Serous Chorioretinopathy.

Authors:  Preeyachan Lourthai; Patama Bhurayanontachai
Journal:  J Ophthalmol       Date:  2017-12-20       Impact factor: 1.909

Review 8.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24

9.  Clinical Factors Associated with Low-Contrast Visual Acuity after Reduced-Fluence Photodynamic Therapy in Patients with Resolved Central Serous Chorioretinopathy and Good Baseline Visual Acuity.

Authors:  Aya Chubachi; Akiko Miki; Mayuka Hayashida; Mari Sakamoto; Hisanori Imai; Sentaro Kusuhara; Makoto Nakamura
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-28

10.  Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study.

Authors:  Seungbum Kang; Young Gun Park; Jae Ryun Kim; Eric Seifert; Dirk Theisen-Kunde; Ralf Brinkmann; Young Jung Roh
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.